Biotoxtech Co Ltd (086040)

KOSDAQ

Currency in KRW

2,975

-45(-1.49%)

Closed·07:29:59

Fair Value

Unlock Value

Day's Range

2,965

3,020

52 wk Range

2,690

5,190

086040 Financial Summary

A brief financial summary of Biotoxtech Co Ltd as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio-6.41

Price/Book1.22

Debt / Equity196.07%

Return on Equity-30.96%

Dividend Yield0.00%

EBITDA-4.52B

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

26,428.63

32,717.39

37,291.74

32,630.98

41,341.49

Gross Profit

aa.aa

6,397.59

10,509.27

12,428.8

1,861.91

2,499.14

Operating Income

aa.aa

537.46

4,631.73

800.05

-8,676.33

-8,619.14

Net Income

aa.aa

2,613.63

7,114.1

2,725.2

-4,877.64

-6,427.24

Balance Sheet

Total Assets

aa.aa

63,654.91

90,740.89

125,700.38

147,036.24

136,191.12

Total Current Liabilities

aa.aa

25,717.58

45,776.63

59,527.93

75,118.53

82,209.55

Total Equity

aa.aa

34,281.58

41,849.36

44,366.87

48,234.83

34,525.46

Cash Flow

Levered Free Cash Flow

aa.aa

1,474.53

1,921.72

-28,440.1

-10,757.27

-7,681.21

Cash from Operations

aa.aa

4,563.71

4,346.25

-1,309.1

-16,238.22

-7,120.23

Cash from Investing

aa.aa

-7,005.16

-7,757.29

-26,398.56

-1,978.36

-9,840.7

Cash from Financing

aa.aa

-141.21

19,278.91

21,928.81

33,022.18

762.48

Net Change in Cash

aa.aa

-2,629.58

15,844.82

-5,892.2

14,779.45

-16,109.12

* In Millions of KRW (except for per share items)

Earnings

Latest Release

May 15, 2025

EPS / Forecast

-94.00 / --

Revenue / Forecast

11.25B / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Biotoxtech's earnings for the latest quarter?

The Biotoxtech EPS (TTM) is -418.46. Biotoxtech reported sales of 11,245.95, net income of -1,477.60, and EPS of -94.00 for the latest quarter.

What was Biotoxtech's net income for the latest quarter?

Biotoxtech's net income for the latest quarter was -1,477.60.

How did Biotoxtech's performance compare year-over-year in the latest quarter?

The company's revenue moved from 11,419.60 in the previous quarter to 11,245.95 in the latest quarter, and net income moved from -2,111.35 to -1,477.60 compared to the previous quarter.

What is Biotoxtech's net profit margin on a TTM basis?

Biotoxtech's trailing twelve months (TTM) net profit margin is -15.55%.

How does Biotoxtech's debt to equity ratio compare to industry standards?

Biotoxtech's total debt-to-equity ratio is 196.07%.

What is Biotoxtech's return on investment on a TTM basis?

Biotoxtech's trailing twelve months (TTM) return on investment (ROI) is -30.96%.

Did Biotoxtech gain or lose cash last quarter?

In the latest quarter, Biotoxtech's net change in cash was 5,972.11 million.

What were Biotoxtech's total assets and liabilities in the latest quarter?

As of the latest quarter, Biotoxtech reported total assets of 133,521.88 million and total liabilities of 82,700.97 million.

How has Biotoxtech's total revenue grown this year?

Biotoxtech's total revenue was 11,419.60 in the previous quarter and 11,245.95 in the latest quarter.

What is Biotoxtech's gross margin on a TTM basis?

Biotoxtech's trailing twelve months (TTM) gross margin is 8.81%.

What was Biotoxtech's revenue per share for the latest quarter?

Biotoxtech's revenue per share for the latest quarter was 12,326.93.

NSE 30

4,944.18

+11.79

+0.24%

NSE All Share

134,827.56

+374.64

+0.28%

US 30

44,953.50

+51.6

+0.11%

US 500

6,403.30

+14.7

+0.23%

FTSE 100

9,113.45

-6.86

-0.08%

DAX

24,285.01

+51.93

+0.21%

South Africa Top 40

91,533.92

+230.52

+0.25%

Market Movers

Name	Last	Chg. %	Vol.
Access Holdings	28.70	+3.61%	7.54M
UBA	46.95	-0.11%	4.70M
Oando Plc	62.35	+3.83%	3.29M
Zenith Bank	73.90	-0.14%	2.14M
Dangote Cement	500.00	+1.42%	1.19M
Geregu Power	1,027.40	-10.00%	1.00M
Okomu Oil Palm	1,030.00	+3.21%	652.19K

Name	Last	Chg. %	Vol.
Airtel Africa	2,541.50	+10.00%	6.00
Champion Brew	13.55	+9.98%	2.54M
Guinness Nigeria	117.05	+9.96%	40.60K
UAC Of Nigeria	56.50	+2.82%	43.99K
Daarcomm	0.89	+9.88%	2.25M
Nem	23.950	+9.86%	34.90K
Tantalizers	2.70	+9.76%	2.31M

Name	Last	Chg. %	Vol.
Geregu Power	1,027.40	-10.00%	1.00M
Abbey Mortgage Bank	7.20	-10.00%	44.29K
Transcorp Power	288.00	-10.00%	83.99K
BUA Foods	453.00	-1.31%	21.31K
Conoil	211.10	-9.98%	9.16K
Livingtrust Mortgage Bank	6.59	-9.97%	2.88K
Aluminum Ex	6.45	-9.79%	12.81K

Trending Stocks

Name	Last	Chg. %	Vol.
Champion Brew	13.55	+9.98%	2.54M
MTN Nigeria	419.90	+4.97%	220.93K
International Breweries	16.20	+6.58%	2.34M
Initiates	17.55	+8.80%	3.64M
Zenith Bank	73.90	-0.14%	2.14M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaa A	499.90	+31.13%	655.52
Aaa A Aaaaaaaaaaaaa	5,250.00	+29.89%	6,819.23
Aaaaaaaa	66.50	+28.34%	85.35
Aa Aaaa A Aaaaaaa	419.90	+10.34%	463.32

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Biotoxtech Co Ltd (086040)

086040 Financial Summary

Key Ratios

Statements Highlights

Earnings

FAQ

What were Biotoxtech's earnings for the latest quarter?

What was Biotoxtech's net income for the latest quarter?

How did Biotoxtech's performance compare year-over-year in the latest quarter?

What is Biotoxtech's net profit margin on a TTM basis?

How does Biotoxtech's debt to equity ratio compare to industry standards?

What is Biotoxtech's return on investment on a TTM basis?

Did Biotoxtech gain or lose cash last quarter?

What were Biotoxtech's total assets and liabilities in the latest quarter?

How has Biotoxtech's total revenue grown this year?

What is Biotoxtech's gross margin on a TTM basis?

What was Biotoxtech's revenue per share for the latest quarter?

Trending Stocks